Details of the Drug Formulaction

General Information of Drug Formulation (ID: F07962)

• Formulation Name: Fenofibrate 145 mg tablet
• Company: Aphena Pharma Solutions-Tennessee; NuCare Pharmaceuticals; Perrigo New York

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Fenofibrate	(DMFKXDY)	Coronary atherosclerosis		Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Beta-D-lactose	(E00099)	6134	Diluent; Dry powder inhaler carrier; Lyophilization aid
Carmellose sodium	(E00625)	Not Available	Disintegrant
Magnesium stearate	(E00208)	11177	lubricant
Sodium lauryl sulfate	(E00464)	3423265	Emulsifying agent; Modified-release agent; Penetration agent; Solubilizing agent; Surfactant; lubricant
Water	(E00035)	962	Solvent